C9275 Injection, hexaminolevulinate hydrochloride, 100 mg, per study dose

Short descriptor: Hexaminolevulinate hcl

⚠ Terminated HCPCS Level II 2026
Terminated Code
C9275 was terminated as of 2018-12-31 and should not be reported for dates of service after that date. This page is retained for historical reference.
Open C9275 in the app →

Look up C9275 alongside ICD-10-CM diagnoses, the HCPCS Table of Drugs, and the AI coding assistant.

C9275 is the HCPCS Level II code for Injection, hexaminolevulinate hydrochloride, 100 mg, per study dose (2026). It belongs to Section C — Outpatient PPS (Hospital). Under Medicare, its coverage status is: Special coverage instructions apply. Part B pricing methodology: Statute.

Classification & CMS Attributes

Medicare Coverage
Special coverage instructions apply (code D)
Part B Pricing
Statute (indicator 53)
Type of Service
Diagnostic radiology
Effective Date
2019-01-01
Termination Date
2018-12-31
2026 Maintenance
No change this year

References

Cite This Page

Reference C9275 with the canonical source and edition:

C9275 — Injection, hexaminolevulinate hydrochloride, 100 mg, per study dose. ICD-10 Coding Pro (HCPCS Level II 2026). https://icd10codingpro.com/hcpcs-codes/C9275

Canonical URL: https://icd10codingpro.com/hcpcs-codes/C9275

Related Codes in Section C

Browse all HCPCS Level II sections →
Reviewed by Prajwal Shrestha, CPC, CRC
Certified Professional Coder (CPC) and Certified Risk Adjustment Coder (CRC) · AAPC Member ID 01997614 · About · Editorial policy · Content last reviewed: 2026-01-01

Get HCC Mappings, Clinical Summaries, and More

Access premium features including HCC risk adjustment, FDA drug indications, AI coding assistant, and comprehensive clinical context.

Start Free Trial